I agree that this site is using cookies. You can find further informations here.
X
Zeng, Sini
50  results:
Search for persons X
?
1

The Impact of Artificial Intelligence on the Technological ..:

Zeng, Sini ; Wang, Meihua
Frontiers in Business, Economics and Management.  15 (2024)  1 - p. 19-24 , 2024
Link: https://doi.org/10.54097..
 
?
2

First-line systemic treatment strategies for unresectable h..:

wang, Liting ; Peng, Ye ; Qin, Shuxia...
PLOS ONE.  18 (2023)  4 - p. e0279786 , 2023
Link: https://doi.org/10.1371/..
 
?
3

Circ_0025039 acts an oncogenic role in the progression of n..:

Wang, Lei ; Zeng, Cimei ; Chen, Zhongren...
Molecular and Cellular Biochemistry.  477 (2022)  3 - p. 743-757 , 2022
Link: https://doi.org/10.1007/..
 
?
4

Clinical Benefit and Cost Effectiveness of Risk-Stratified ..:

Qin, Shuxia ; Wang, Xuehong ; Li, Sini...
PharmacoEconomics.  40 (2022)  7 - p. 725-737 , 2022
Link: https://doi.org/10.1007/..
 
?
5

Cost-Effectiveness of Bevacizumab Biosimilar LY01008 Combin..:

Luo, Xia ; Liu, Qiao ; Zhou, Zhen...
Frontiers in Pharmacology.  13 (2022)  - p. , 2022
Link: https://doi.org/10.3389/..
 
?
6

Sintilimab Plus Bevacizumab Biosimilar Versus Sorafenib as ..:

Peng, Ye ; Zeng, Xiaohui ; Peng, Liubao...
Frontiers in Pharmacology.  13 (2022)  - p. , 2022
Link: https://doi.org/10.3389/..
 
?
7

Benefit-to-harm ratio and cost-effectiveness of government-..:

Qin, Shuxia ; Wang, Xuehong ; Li, Sini...
Frontiers in Public Health.  10 (2022)  - p. , 2022
Link: https://doi.org/10.3389/..
 
?
8

Cost-Effectiveness of Ipilimumab Plus Anti-PD-1 Therapy Ver..:

Peng, Ye ; Zeng, Xiaohui ; Peng, Liubao...
Frontiers in Oncology.  11 (2021)  - p. , 2021
Link: https://doi.org/10.3389/..
 
?
9

First-line Daratumumab in Addition to Chemotherapy for Newl..:

Li, SiNi ; Li, JianHe ; Peng, LiuBao...
Clinical Therapeutics.  43 (2021)  7 - p. 1253-1264.e5 , 2021
Link: https://doi.org/10.1016/..
 
?
10

Cost-Effectiveness Analysis of Adding Daratumumab to a Regi..:

Zeng, Xiaohui ; Liu, Qiao ; Peng, Liubao...
Advances in Therapy.  38 (2021)  5 - p. 2379-2390 , 2021
Link: https://doi.org/10.1007/..
 
?
11

Cost-Effectiveness Analysis of Cemiplimab Versus Chemothera..:

Wang, Liting ; Peng, Ye ; Zeng, Xiaohui...
Advances in Therapy.  38 (2021)  8 - p. 4354-4365 , 2021
Link: https://doi.org/10.1007/..
 
?
12

Tofacitinib in the Treatment of Moderate-to-Severe Rheumato..:

Tan, Chongqing ; Li, Sini ; Yi, Lidan...
Advances in Therapy.  38 (2021)  5 - p. 2571-2585 , 2021
Link: https://doi.org/10.1007/..
 
?
13

Sequences of biological treatments for patients with modera..:

Tan, Chongqing ; Luo, Xia ; Li, Sini...
Clinical Rheumatology.  41 (2021)  1 - p. 63-73 , 2021
Link: https://doi.org/10.1007/..
 
?
14

Cost-Effectiveness of Atezolizumab Plus Chemotherapy as Fir..:

Qin, Shuxia ; Yi, Lidan ; Li, Sini...
Advances in Therapy.  , 2021
Link: https://doi.org/10.1007/..
 
?
15

First-Line Atezolizumab for Metastatic NSCLC with High PD-L..:

Peng, Ye ; Zeng, Xiaohui ; Peng, Liubao...
Advances in Therapy.  38 (2021)  5 - p. 2447-2457 , 2021
Link: https://doi.org/10.1007/..
 
1-15